Literature DB >> 30006917

Long-term follow-up of nailfold videocapillaroscopic changes in dermatomyositis versus systemic sclerosis patients.

C Pizzorni1, M Cutolo2, A Sulli1, B Ruaro1, A C Trombetta1, G Ferrari1, G Pesce3, V Smith4, S Paolino1.   

Abstract

To identify nailfold videocapillaroscopy (NVC) changes in patients with dermatomyositis (DM) during a 3-year follow-up and to compare the NVC findings between DM and systemic sclerosis (SSc) patients at their first visit. Retrospective study of 24 DM and 24 SSc patients, matched for age and disease duration at first NVC. Capillaroscopic patterns/scores and clinical parameters had been yearly assessed. Nineteen out of 24 DM patients (79%) showed a NVC "scleroderma-like pattern." No statistically significant variation of all the capillaroscopic scores was observed during the 3-year follow-up. By comparing DM patients with or without anti-Jo-1 positivity, no statistically significant difference of the scores of the main capillary parameters was observed at baseline between the groups. Comparing at baseline DM with SSc patients, the giant capillary and microhemorrhage scores were significantly higher in SSc than those in DM patients (p = 0.04 and p = 0.05, respectively), while capillary density, ramification (abnormally shaped capillaries, expression of angiogenesis), and disorganization scores were higher in DM patients (p = 0.05, p = 0.002, p = 0.004, respectively). The absolute number of ramified capillaries was significantly higher in DM patients (p = 0.002), while the absolute capillary number was significantly higher in SSc patients (p = 0.05) at baseline. This pilot study demonstrates, for the first time, over long-term, that the capillaroscopic manifestations of DM persist in contrast to the progressive changes described in SSc patients, and the anti-Jo-1 positivity does not seem to modify the NVC pattern.

Entities:  

Keywords:  Anti-Jo1 antibodies; Dermatomyositis; Microcirculation; Nailfold capillaroscopy; Systemic sclerosis

Mesh:

Year:  2018        PMID: 30006917     DOI: 10.1007/s10067-018-4211-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  37 in total

Review 1.  How to perform and interpret capillaroscopy.

Authors:  Maurizio Cutolo; Alberto Sulli; Vanessa Smith
Journal:  Best Pract Res Clin Rheumatol       Date:  2013-04       Impact factor: 4.098

2.  Reliability of the qualitative and semiquantitative nailfold videocapillaroscopy assessment in a systemic sclerosis cohort: a two-centre study.

Authors:  Vanessa Smith; Carmen Pizzorni; Filip De Keyser; Saskia Decuman; Jens T Van Praet; Ellen Deschepper; Alberto Sulli; Maurizio Cutolo
Journal:  Ann Rheum Dis       Date:  2010-05-03       Impact factor: 19.103

3.  Quantitative nailfold video capillaroscopy in patients with idiopathic inflammatory myopathy.

Authors:  Louise K Mercer; Tonia L Moore; Hector Chinoy; Andrea K Murray; Andy Vail; Robert G Cooper; Ariane L Herrick
Journal:  Rheumatology (Oxford)       Date:  2010-05-18       Impact factor: 7.580

4.  Nailfold capillaroscopic changes in dermatomyositis and polymyositis.

Authors:  A Manfredi; M Sebastiani; G Cassone; N Pipitone; D Giuggioli; M Colaci; C Salvarani; C Ferri
Journal:  Clin Rheumatol       Date:  2014-10-17       Impact factor: 2.980

Review 5.  Reliability of simple capillaroscopic definitions in describing capillary morphology in rheumatic diseases.

Authors:  Maurizio Cutolo; Karin Melsens; Ariane L Herrick; Ivan Foeldvari; Ellen Deschepper; Filip De Keyser; Oliver Distler; Francesca Ingegnoli; Yora Mostmans; Ulf Müller-Ladner; Carmen Pizzorni; Valeria Riccieri; Barbara Ruaro; Alberto Sulli; Amelia C Trombetta; Amber Vanhaecke; Vanessa Smith
Journal:  Rheumatology (Oxford)       Date:  2018-04-01       Impact factor: 7.580

6.  Nailfold capillaroscopy in systemic sclerosis: data from the EULAR scleroderma trials and research (EUSTAR) database.

Authors:  Francesca Ingegnoli; Ilaria Ardoino; Patrizia Boracchi; Maurizio Cutolo
Journal:  Microvasc Res       Date:  2013-06-17       Impact factor: 3.514

Review 7.  Polymyositis and dermatomyositis.

Authors:  Marinos C Dalakas; Reinhard Hohlfeld
Journal:  Lancet       Date:  2003-09-20       Impact factor: 79.321

Review 8.  NIH conference. Myositis: immunologic contributions to understanding cause, pathogenesis, and therapy.

Authors:  P H Plotz; L G Rider; I N Targoff; N Raben; T P O'Hanlon; F W Miller
Journal:  Ann Intern Med       Date:  1995-05-01       Impact factor: 25.391

Review 9.  An update on inflammatory myositis in children.

Authors:  Adam Huber; Brian M Feldman
Journal:  Curr Opin Rheumatol       Date:  2013-09       Impact factor: 5.006

10.  Longterm treatment with endothelin receptor antagonist bosentan and iloprost improves fingertip blood perfusion in systemic sclerosis.

Authors:  Maurizio Cutolo; Barbara Ruaro; Carmen Pizzorni; Francesca Ravera; Vanessa Smith; Giuseppe Zampogna; Sabrina Paolino; Bruno Seriolo; Marco Cimmino; Alberto Sulli
Journal:  J Rheumatol       Date:  2014-04-01       Impact factor: 4.666

View more
  2 in total

1.  Nailfold capillaroscopy in rheumatology: ready for the daily use but with care in terminology.

Authors:  Maurizio Cutolo; Sabrina Paolino; Vanessa Smith
Journal:  Clin Rheumatol       Date:  2019-08-08       Impact factor: 2.980

2.  Antiphospholipid antibodies and anticoagulant therapy: capillaroscopic findings.

Authors:  Giorgia Ferrari; Emanuele Gotelli; Vanessa Smith; Maurizio Cutolo; Sabrina Paolino; Giampaola Pesce; Luca Nanni; Barbara Maria Colombo; Greta Pacini; Carlotta Schenone; Carmen Pizzorni; Alberto Sulli
Journal:  Arthritis Res Ther       Date:  2021-06-27       Impact factor: 5.156

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.